Biodyne Statistics
Total Valuation
Biodyne has a market cap or net worth of KRW 469.38 billion. The enterprise value is 449.73 billion.
| Market Cap | 469.38B |
| Enterprise Value | 449.73B |
Important Dates
The last earnings date was Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biodyne has 29.76 million shares outstanding. The number of shares has increased by 1.13% in one year.
| Current Share Class | 29.76M |
| Shares Outstanding | 29.76M |
| Shares Change (YoY) | +1.13% |
| Shares Change (QoQ) | -2.64% |
| Owned by Insiders (%) | 42.08% |
| Owned by Institutions (%) | 0.44% |
| Float | 17.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 94.24 |
| PB Ratio | 11.00 |
| P/TBV Ratio | 11.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5,718.50 |
| EV / Sales | 90.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -260.86 |
Financial Position
The company has a current ratio of 27.99, with a Debt / Equity ratio of 0.00.
| Current Ratio | 27.99 |
| Quick Ratio | 26.40 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.00 |
| Interest Coverage | -9,087.58 |
Financial Efficiency
Return on equity (ROE) is -0.18% and return on invested capital (ROIC) is -2.14%.
| Return on Equity (ROE) | -0.18% |
| Return on Assets (ROA) | -2.09% |
| Return on Invested Capital (ROIC) | -2.14% |
| Return on Capital Employed (ROCE) | -3.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.11 |
| Inventory Turnover | 3.28 |
Taxes
| Income Tax | -145.90M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.37% in the last 52 weeks. The beta is 1.60, so Biodyne's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | -9.37% |
| 50-Day Moving Average | 14,072.20 |
| 200-Day Moving Average | 14,438.25 |
| Relative Strength Index (RSI) | 65.87 |
| Average Volume (20 Days) | 107,858 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodyne had revenue of KRW 4.98 billion and -78.64 million in losses. Loss per share was -2.66.
| Revenue | 4.98B |
| Gross Profit | 3.02B |
| Operating Income | -1.46B |
| Pretax Income | -224.54M |
| Net Income | -78.64M |
| EBITDA | -60.28M |
| EBIT | -1.46B |
| Loss Per Share | -2.66 |
Balance Sheet
The company has 19.66 billion in cash and 3.97 million in debt, giving a net cash position of 19.65 billion or 660.31 per share.
| Cash & Cash Equivalents | 19.66B |
| Total Debt | 3.97M |
| Net Cash | 19.65B |
| Net Cash Per Share | 660.31 |
| Equity (Book Value) | 42.67B |
| Book Value Per Share | 1,486.89 |
| Working Capital | 20.90B |
Cash Flow
In the last 12 months, operating cash flow was -1.04 billion and capital expenditures -686.85 million, giving a free cash flow of -1.72 billion.
| Operating Cash Flow | -1.04B |
| Capital Expenditures | -686.85M |
| Free Cash Flow | -1.72B |
| FCF Per Share | -57.92 |
Margins
Gross margin is 60.58%, with operating and profit margins of -29.37% and -1.58%.
| Gross Margin | 60.58% |
| Operating Margin | -29.37% |
| Pretax Margin | -4.51% |
| Profit Margin | -1.58% |
| EBITDA Margin | -1.21% |
| EBIT Margin | -29.37% |
| FCF Margin | n/a |
Dividends & Yields
Biodyne does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.13% |
| Shareholder Yield | -1.13% |
| Earnings Yield | -0.02% |
| FCF Yield | -0.37% |
Stock Splits
The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Feb 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |